Professor
Victor Tetz
Second Life Therapeutics
Meet SLT
Redefining Cancer
Treatment
At Second Life Therapeutics, we are reshaping how difficult-to-treat and refractory solid tumors are approached, including cancers once considered “untreatable”
Our Breakthrough Therapy: SL‑28
We are a clinical-stage biopharmaceutical company advancing Leukocyte-Tells (SL‑28), the first-in-class, allogeneic, non-genetically modified adoptive cell therapy. SL‑28 therapy is tumor-agnostic, highly active against solid tumors, ready-to-use, and based on a New Biology concept overcoming the limitations of current approaches.
The Science Behind SL‑28
Our scientists and medical team discovered the Universal Receptive System and its unique Teazeled receptors (TezRs) through which, for the first time, we can modulate cellular memory. We transform donor-derived immune cells into Leukocyte-Tells (SL‑28) that are capable of targeting a broad spectrum of solid tumors with unprecedented levels of response. Our science has unlocked anticancer mechanisms that were previously unknown.
Why SL-28
-
Cancer-agnostic
01Designed to address multiple tumor types resistant to current therapies.
-
Ready-to-use
02immediate access for patients, avoiding the long delays of custom manufacturing typical for other cell-therapies.
-
Refractory solid tumors
03SL-28 works on “untreatable” and treatment-refractory solid tumors, and uses several novel anticancer mechanisms that were recently discovered by our team of scientists.
Who we are
Second Life Therapeutics is part of Second Life Group, a collective of biotech companies addressing medicine's most critical, unmet needs, with science and technology developed in close collaboration with Tetz Laboratories in New York. Together, we are pioneering a new generation of therapies that bring hope to patients facing the most challenging cancers.
At Second Life Therapeutics,
Therapeutics,
we treat the most advanced
most advanced
and refractory tumors, providing
tumors, providing
a second chance at
chance at
life for patients in need
in need
This is some text inside of a div block.
This is some text inside of a div block.
Founders
scientific
Second Life Therapeutics is led by an accomplished team of physicians and scientists with extensive experience in biotechnology and drug development who consider their science as a form of art.
George Tetz
New York
Second Life Therapeutics is a global company with scientific sites on two continents in the United States and Australia, aimed to bring the innovation of the Universal Receptive System to those in need.
California
Manufacturing
Second Life Therapeutics partners with leading manufacturing experts to ensure that Leukocyte-Tells (SL-28) reach patients rapidly, reliably, and at the highest quality.
Safety and Quality
Working hand in hand with the manufacturing facility, Second Life Therapeutics team oversees every stage of clinical-grade production and quality control. This guarantees consistency, safety, and reproducibility across all batches.
Supporting Patients and Trials
With the integrated approach, we deliver a dependable supply of SL-28 to power our clinical development programs and to patients receiving treatment through expanded access pathway.
Australia
